Further, since many of the medications (statins, angiotensin-converting enzyme inhibitors and receptor antagonists, and glucose-lowering medication) are known to improve endothelial function (23), they would be expected to result in an underestimation of the endothelial dysfunction observed following incubation with RBC-derived EVs from patients taking these medications. Here, ACE is linked to endothelial dysfunction.